NHS Framework - Blood Disorders including Haemophilia A and B - July 2024
Buyer: NHS England
- Published
- 11 June 2024
- Estimated value
- £31
- Place of performance
- UK
- Procedure
- Open procedure
- Notice number
- 018011-2024
- Reference
- ocds-h6vhtk-043b0e
- Official source
- Official source
CPV codes
- 33600000Pharmaceutical products
Description
Project Title: NHS National Framework Agreement for the supply of products for the treatment of Blood Disorders including Haemophilia A and B - July 2024 Offer reference number: CM/PHS/22/5661 Period of framework: 1 July 2024 to 30 April 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 14 months. Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England
Lots (23)
| Lot | Description | CPV code | Amount |
|---|---|---|---|
| 1 | CM/PHS/22/5661/01 Standard Half-life Recombinant Factor VIII | 33600000 Pharmaceutical products | — |
| 2 | CM/PHS/22/5661/02 Enhanced Half-life Recombinant Factor VIII | 33600000 Pharmaceutical products | — |
| 3 | CM/PHS/22/5661/03 Emicizumab | 33600000 Pharmaceutical products | — |
| 4 | CM/PHS/22/5661/04 eftrenonacog alfa (rFIX EHL) | 33600000 Pharmaceutical products | — |
| 5 | CM/PHS/22/5661/05 albutrepenonacog alfa (rFIX EHL) | 33600000 Pharmaceutical products | — |
| 6 | CM/PHS/22/5661/06 nonacog beta pegol (rFIX EHL) | 33600000 Pharmaceutical products | — |
| 7 | CM/PHS/22/5661/07 rFIX - Standard Half Life | 33600000 Pharmaceutical products | — |
| 8 | CM/PHS/22/5661/08 Recombinant Factor VII | 33600000 Pharmaceutical products | — |
| 9 | CM/PHS/22/5661/09 Porcine Factor VIII - susoctocog alfa | 33600000 Pharmaceutical products | — |
| 10 | CM/PHS/22/5661/10 Factor VIII Inhibitor Bypassing Fraction | 33600000 Pharmaceutical products | — |
| 11 | CM/PHS/22/5661/11 Factor IX - High Purity Factor IX | 33600000 Pharmaceutical products | — |
| 12 | CM/PHS/22/5661/12 Factor X | 33600000 Pharmaceutical products | — |
| 13 | CM/PHS/22/5661/13 Factor XIII - Plasma Derived | 33600000 Pharmaceutical products | — |
| 14 | CM/PHS/22/5661/14 Factor XIII - Recombinant | 33600000 Pharmaceutical products | — |
| 15 | CM/PHS/22/5661/15 Von willebrands factor / Factor VIII | 33600000 Pharmaceutical products | — |
| 16 | CM/PHS/22/5661/16 Von willebrands factor - Plasma Derived | 33600000 Pharmaceutical products | — |
| 17 | CM/PHS/22/5661/17 Von willebrands factor - Recombinant | 33600000 Pharmaceutical products | — |
| 18 | CM/PHS/22/5661/18 Fibrinogen Concentrate | 33600000 Pharmaceutical products | — |
| 19 | CM/PHS/22/5661/19 Prothrombin Complex dried | 33600000 Pharmaceutical products | — |
| 20 | CM/PHS/22/5661/20 Protein C Concentrate | 33600000 Pharmaceutical products | — |
| 21 | CM/PHS/22/5661/21 Fresh Frozen Plasma (all blood groups) | 33600000 Pharmaceutical products | — |
| 22 | CM/PHS/22/5661/22 Freeze Dried Plasma | 33600000 Pharmaceutical products | — |
| 23 | CM/PHS/22/5661/23 Caplacizumab | 33600000 Pharmaceutical products | — |
Awards
| Awarded to | Amount | Date |
|---|---|---|
| Takeda UK Ltd | — | — |
| Octapharma Limited | — | — |
| Novo Nordisk | — | — |
| Sobi (Swedish Orphan Biovitrum Ltd) | — | — |
| Roche Products Ltd | — | — |
| Sobi (Swedish Orphan Biovitrum Ltd) | — | — |
| Novo Nordisk | — | — |
| Pfizer Ltd | — | — |
| Takeda UK Ltd | — | — |
| Pfizer Ltd | — | — |
Official publications
- FTS · 018011-2024 · 11 June 2024
Other tenders from NHS England
- Enhanced Mental Health Pathway
- Enhanced Mental Health Pathway
- NHS Vaccination and Immunisation Services
- NHS Vaccination and Immunisation Services
- Fertility service for preservation and use of reproductive tissue for service users who cannot store mature eggs/sperm who are at high/very…
- Integrated Healthcare Services at HMP Welland Oaks
- Tier 4 Lead Provider for CAMHS
- Onasemnogene Abeparvovec Intravenous (Zolgensma®) Service & Onasemnogene Abeparvovec Intrathecal (OAV101 IT) Service
- Black Country Covid-19 Targeted Outreach Intervention: Mobile vaccination provision
- Covid Vaccinations to Nottinghamshire Housebound Patients
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is £31.
- Who is the buyer of this tender?
- The contracting authority is NHS England (United Kingdom).
- How can I bid for public tenders in the United Kingdom?
- Bids are submitted through the official public procurement portal in the United Kingdom. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.